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Abstract
Purpose:Orbital cellulitis (OC) is a rare postoperative complication of glaucomadrainage
device (GDD) implantation. To date, there have only been 10 reported cases of OC
following GDD implantation.
Case Report: Here, we report a case of OC in a 57-year-old man who developed
pain, proptosis, and limited extraocular motility two days after uneventful Ahmed
FP7 implantation in the right eye. Contrast-enhanced computed tomography of the
orbits demonstrated fat stranding and a small fluid collection, consistent with OC. He
had minimal improvement with intravenous antibiotics and ultimately underwent GDD
explantation. A systematic review of the literature showed that the development of
OC following GDD implantation can occur in the early or late postoperative period.
Immediate hospitalization with intravenous administration of broad-spectrum antibiotics
is recommended. Explantation of the infected GDD is often required for source control.
Conclusion: OC is a rare postoperative complication of GDD implantation. Prompt
evaluation and treatment are required, often combined with GDD explantation.
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INTRODUCTION
Glaucoma drainage devices (GDDs) are surgical
devices commonly implanted in eyes with
Correspondence to:
Cindy X. Zheng, MD. Wills Eye Hospital Glaucoma
Research Center, 840 Walnut St., Suite 1140,
Philadelphia, PA 19107, USA.
E-mail: cindyzheng9@gmail.com
Received: 29-05-2019 Accepted: 31-08-2019
Access this article online
Website: https://knepublishing.com/index.php/JOVR
DOI: 10.18502/jovr.v15i3.7460
refractory glaucoma. The development of orbital
cellulitis (OC) following GDD implantation is rare,
with only 10 reported cases in the literature.[1–9]
Here, we report a case of OC following the
placement of an Ahmed FP7 (New World Medical,
Rancho Cucamonga, CA) in a 57-year-old man who
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Figure 1. External photograph of the affected eye on the day of presentation, demonstrating periorbital edema, erythema,
conjunctival injection, and chemosis.
Figure 2. Contrast-enhanced computed tomography of the orbits showing findings consistent with orbital cellulitis, including
proptosis of the right globe, thickening of the sclera and optic nerve insertion, small superior fluid collection, and mild anterior
retrobulbar fat stranding (A). An Ahmed tube shunt and Baerveldt tube shunt are visualized in the right and left globes, respectively
(B).
showed minimal improvement with intravenous
(IV) antibiotics and ultimately underwent GDD
explantation.
CASE REPORT
A 57-year-old incarcerated man with advanced
primary open-angle glaucoma was referred to us
because of poorly controlled intraocular pressure
(IOP). He had a surgical history of bilateral
trabeculectomy and implantation of a Baerveldt
tube shunt implanted in the left eye approximately
nine years ago. He had a medical history of
gastroesophageal reflux disease and was not on
any routine medications other than his glaucoma
medications. On presentation, his visual acuity (VA)
was 20/200 in the right eye and light perception in
the left eye. His IOP was 13 mmHg in the right eye
and 12 mmHg in the left eye on maximum topical
therapy and oral acetazolamide. Due to difficulty
tolerating acetazolamide, he agreed to proceed
with Ahmed FP7 implantation in the right eye.
GDD was implanted uneventfully with Tutoplast
processed sclera patch graft (Katena Products Inc.,
Denville, NJ) in the superonasal quadrant because
of conjunctival scarring from prior trabeculectomy.
No intraoperative injections or mitomycin C were
given. On postoperative day 1, he had a VA of
20/200 and an IOP of 10mmHg, and the tube shunt
was covered and well-positioned.
The patient presented emergently on
postoperative day 4 because of two days of
right eye pain, swelling, and blurry vision. He
reported that he did not receive his postoperative
topical ofloxacin or prednisolone acetate drops
from his facility. VA was hand motion and IOP was
20 mmHg. Externally, the right orbit was tense
with lid erythema and edema. His right globe was
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proptotic with limited extraocular motility (Figure
1). There was a small opening in the conjunctiva
over the patch graft, located 4 mm posterior to the
limbus. A sample of purulent drainage from this
opening was swabbed and sent for microbiologic
testing. The anterior chamber was deep with rare
cells. There was no vitritis. Contrast-enhanced
computed tomography (CT) demonstrated soft-
tissue thickening, fatty infiltration, and a small fluid
collection superiorly (Figure 2).
He was admitted for administration of IV
vancomycin and piperacillin-tazobactam and
topical fortified vancomycin and tobramycin. On
hospitalization day 2, he received 8 mg of IV
dexamethasone. Improvement was minimal with
the administration of IV antibiotics for 24 hours;
therefore, surgical explantation of the GDD was
performed.
Intraoperatively, there was an area of
conjunctival melt over the tube with pockets
of purulent material surrounding the valve. To
prevent intraocular penetration of the infected
material into the anterior chamber, a purse-
string suture was passed around the tube
entry site in the sclera and was tied-off while
a surgical assistant withdrew the tube. The
plate and tube were noted to be completely
free, presumably because of the surrounding
scleritis. The implant was removed, and the
area was copiously irrigated with vancomycin
and ceftazidime solution. After conjunctival
closure with 8-0 Vicryl sutures, subconjunctival
injections of vancomycin and ceftazidime
were administered. Considering the patient’s
monocular status with advanced glaucoma in the
affected eye and a history of poorly controlled
IOP, concomitant MicroPulse transscleral
cyclophotocoagulation (Iridex Corp., Mountain
View, CA) was performed for 140 sec to the inferior
globe at a power of 2000mW and duty cycle of
31.3%.
Cultures showed light growth of methicillin-
susceptible Staphylococcus aureus and
Cutibacterium acnes (formerly Propionibacterium
acnes). He was discharged two days after the tube
shunt explantation with oral moxifloxacin 400 mg
and topical fortified vancomycin and gatifloxacin.
Six months after the surgery, VA was hand
motion and IOP was 12 mmHg with three
topical glaucoma medications. He had complete
resolution of orbital signs.
DISCUSSION
A systematic literature review revealed a total of
11 cases of OC following GDD surgery, including
the present case (Table 1). Most patients presented
within two days of symptom onset.[1–8] On
presentation, all patients had eyelid erythema
and edema, and most patients had chemosis,
proptosis or globe displacement, and limited
extraocular motility.
The most common GDD associated with
post-implantation OC was the Ahmed valve (n
= 7),[2–7] although Molteno,[1] Krupin–Denver,[2]
and Baerveldt[8, 9] implants have also been
associated with post-implantation OC. In seven
cases, symptoms of OC started in the immediate
postoperative period (≤ 3 months after the
surgery).[1, 2, 5–8] In the other four cases, OC
developed after the postoperative month 3.[2–4, 9]
In three of the four cases of delayed-onset
OC,[2, 4, 9] the tube was exposed, presumably
serving as a conduit for bacteria to travel from
the ocular surface into the orbit. In one case of
delayed-onset OC, the tube was not specifically
exposed; however, the patient had concurrent
endophthalmitis.[3] The authors theorized that
organisms may have gained entry into the eye
from the ocular surface and OC from drainage via
the tube.[3]
Table 2 summarizes the management of OC.
CT is the imaging modality of choice for OC
and was the most common modality used.[10] All
patients were hospitalized and administered IV
antibiotics. Although the choice of antibiotic varied,
the consensus was to start with broad-spectrum
coverage. In the present case, vancomycin was
used owing to previous studies showing a high
prevalence of methicillin-resistant Staphylococcus
aureus isolated from ocular infections.[11] The
antibiotic coverage changed based on infectious
disease consultation or culture sensitivities. Topical
antibiotics were commonly used.[1–5, 7, 8]
Although not routinely administered, IV steroids
were used in two cases after the administration of
IV antibiotics for 24 hours, including our case.[9]
We administered steroids under the guidance
of oculoplastic consultation to reduce orbital
inflammation and to improve the ease of access
during GDD explantation. Previous studies have
shown that steroids can help reduce the cytokine
load and improve outcomes in bacterial OC.[12, 13]
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Blood cultures were negative in all tested
cases.[1, 3–5, 7] Presumably, the infection remained
localized to the orbit. Since all cases presented
within three days of symptom onset, the infection
was rapidly managed with antibiotics, thus,
bacteremia was less likely to occur.
The GDD was surgically explanted in 8 of the
11 cases,[1–5, 7, 9] including all five cases of tube
exposure[1, 2, 4, 9] and all three cases of concurrent
endophthalmitis.[3–5] Presumably, erosion allowed
bacteria to seed the GDD, and the infection
may be difficult to clear without explanting the
infected GDD. Explantation was performed in
all children aged less than three years.[1–5] In
this age group, it is difficult to perform an
examination without the use of general anesthesia;
therefore, it may be safer to perform explantation
at the initial examination than to subject the
patient to repeated episodes of anesthesia. In all
cases of explantation, GDDs were most frequently
explanted within one to two days of presentation,
suggesting that failure to respond to antibiotics
can be quickly identified. During explantation,
the area surrounding the tube was irrigated with
antibiotics,[1, 4] or subconjunctival or sub-Tenon’s
injection of antibiotics were performed.[2–5, 7] In
three cases, there was a sufficient improvement
with IV antibiotics alone; consequently, no surgical
interventions were undertaken.[2, 6, 8]
When IV antibiotics were transitioned to
oral antibiotics, fluoroquinolones were most
commonly used,[4, 7–9] likely owing to their vitreous
penetration and relatively broad coverage.[14] The
duration was most commonly 10 days, as seen in
four cases.[2, 5, 8] The duration of the therapy was
likely associated with the severity of presentation
and response to therapy. Table 3 details the
outcomes and additional procedures that were
performed.
In conclusion, OC is a rare postoperative
complication of GDD implantation. Immediate
hospitalization with administration of broad-
spectrum IV antibiotics is recommended.
Explantation of the GDD is often required for
source control.
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